2.2992
前日終値:
$2.34
開ける:
$2.27
24時間の取引高:
12,320
Relative Volume:
0.40
時価総額:
$2.26M
収益:
$7.68M
当期純損益:
$-34.33M
株価収益率:
-0.0261
EPS:
-88.1566
ネットキャッシュフロー:
$-19.17M
1週間 パフォーマンス:
+4.04%
1か月 パフォーマンス:
-28.15%
6か月 パフォーマンス:
-78.69%
1年 パフォーマンス:
-94.25%
Beyond Air Inc Stock (XAIR) Company Profile
Compare XAIR vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
XAIR
Beyond Air Inc
|
2.2992 | 2.26M | 7.68M | -34.33M | -19.17M | -88.16 |
|
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-09-01 | 開始されました | Lake Street | Buy |
| 2025-07-17 | 開始されました | D. Boral Capital | Buy |
| 2024-06-25 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-07-28 | 開始されました | Piper Sandler | Overweight |
| 2023-06-15 | 開始されました | BTIG Research | Buy |
| 2021-04-28 | 開始されました | Truist | Buy |
| 2019-10-22 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Beyond Air Inc (XAIR) 最新ニュース
A 14.8% stake falls below the 10% ownership threshold at Beyond Air (XAIR). - Stock Titan
Five directors face election at Beyond Air (XAIR), alongside a nonbinding executive-pay vote. - Stock Titan
Beyond Air Stock Price Forecast. Should You Buy XAIR? - StockInvest.us
Form 4 Beyond Air Inc: Yi-Chien Lin (10% Owner) For: 13 October - Investing.com Nigeria
Beyond Air director Lin Yi-Chien buys $5,761 in company stock By Investing.com - Investing.com South Africa
Beyond Air director Lin Yi-Chien buys $5,761 in company stock - Investing.com
Form 4 Beyond Air Inc: Yi-Chien Lin (10% Owner) For: 13 October - Investing.com Canada
Form 4 Beyond Air Inc: Yi-Chien Lin (10% Owner) For: 13 October - Investing.com UK
At $2.21 a share, Beyond Air (XAIR) ten percent owner Lin Yi-Chien buys 2,607 shares. - Stock Titan
Beyond Air director Lin Yi-Chien buys $5,761 in company stock - Investing.com Nigeria
Top insider buys and sells disclosed on Friday - Investing.com
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com UK
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com Nigeria
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com Australia
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com UK
A 10% owner buys 20,393 shares of Beyond Air (XAIR) in three direct purchases. - Stock Titan
Ten percent owner Lin Yi-Chien holds 125,000 shares directly in Beyond Air (XAIR). - Stock Titan
Form 3 Beyond Air, Inc. For: Sep 28 Filed by: Lin Yi-Chien - StreetInsider
One holder reports sole voting power over 145,393 Beyond Air (XAIR) shares. - Stock Titan
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com Canada
Why Beyond Meat (BYND) Shares Are Getting Obliterated Today - Yahoo Finance
XAIR: Generation 2 device approval is set to unlock a $400M+ market with immediate deployment planned - TradingView
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com Canada
XAIR: Generation 2 enables immediate entry into the $400M U.S. transport market upon FDA approval - TradingView
Beyond Air at cantors conference: generation 2 is the focus - Investing.com India
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com UK
At the Waldorf Astoria, Beyond Air joins a healthcare conference Sept. 10 - Stock Titan
XAIR Initiates Coverage On Beyond Air -- Rating Set to Buy - GuruFocus
ENvue Medical Announces Reverse Stock Split to Reduce Shares to 923,718 (NASDAQ: FEED) - Kalkine Media
Lake Street Initiates Beyond Air at Buy With $10 Price Target - marketscreener.com
XAIR Looks 98.9% Undervalued on GF Value™ Despite Financial Stru - GuruFocus
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - The Manila Times
Beyond Air Announces FDA Breakthrough Device Designation for LungFit GO in NTM-PD Treatment - Quiver Quantitative
A portable treatment for hard-to-treat lung infections gets FDA breakthrough status - Stock Titan
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - Yahoo Finance
Beyond Air to Sell NeuroNOS Stake to UNIVO in Equity, Milestone Deal - citybiz
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com Nigeria
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com India
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - marketscreener.com
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - Yahoo Finance
Balyasny Asset Management L.P. Buys Beyond Air Inc (XAIR) -- Sha - GuruFocus
Beyond Air | 8-K: Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update - Moomoo
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Nigeria
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com India
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com UK
Beyond Air (NASDAQ: XAIR) resale may lift share count to 6.2M - Stock Titan
Beyond Air Q2 net loss hits USD 7.9M - Medical Buyer
Cash per share of Beyond Air, Inc. – FWB:48L - TradingView
Beyond Air Inc (XAIR) 財務データ
収益
当期純利益
現金流量
EPS
Beyond Air Inc (XAIR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lin Yi-Chien | 10% Owner |
Oct 01 '26 |
Buy |
2.80 |
15,393 |
43,100 |
145,393 |
| Lin Yi-Chien | 10% Owner |
Sep 30 '26 |
Buy |
2.71 |
2,000 |
5,420 |
130,000 |
| Lin Yi-Chien | 10% Owner |
Sep 29 '26 |
Buy |
2.69 |
3,000 |
8,070 |
128,000 |
| Goodman Robert Scott | Chief Executive Officer |
Jul 29 '26 |
Buy |
5.76 |
34,722 |
199,999 |
34,822 |
| MOORHEAD DANIEL J | Chief Financial Officer |
Jul 29 '26 |
Buy |
5.76 |
4,340 |
24,998 |
4,340 |
大文字化:
|
ボリューム (24 時間):